Truxima

Truxima is a medication used to treat certain blood cancers, such as non-Hodgkin lymphomas and chronic lymphocytic leukemia. It contains rituximab, a protein that targets specific white blood cells called B-cells, which can become cancerous. By attaching to these cells, Truxima helps the immune system recognize and destroy them, reducing cancer growth. It is typically administered through an IV in a healthcare setting. Truxima is part of targeted therapy, offering a treatment option that specifically attacks cancer cells while aiming to minimize damage to healthy tissue.